Osiris Therapeutics (OSIR) Posts Narrower than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Total operating expenses: 19.63M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Financial Fact:
Total operating expenses: 19.63M
Today's EPS Names:
DGICA, UXIN, TOWN, More
Join SI Premium – FREE
Osiris Therapeutics (NASDAQ: OSIR) reported Q1 EPS of ($0.04), $0.05 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $3.45 million versus the consensus estimate of $3.45 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- DTE Energy (DTE) Misses Q1 EPS by 17c
- HarborOne Bancorp, Inc. (HONE) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
